← Open Payments lookup

ANDREA HOLZMAN: Open Payments

NPI 1760903173 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,097 in 55 payments from 14 companies in 2025. Trend: 2023 $989 · 2024 $1,395 · 2025 $1,097

Food & beverage: $1,097
CompanyPaymentsAmount
Novo Nordisk Inc15$245
PFIZER INC.10$184
AstraZeneca Pharmaceuticals LP5$116
Lilly USA, LLC4$86
Abbott Laboratories4$82
GlaxoSmithKline, LLC.4$81
Astellas Pharma US Inc3$71
ABBVIE INC.2$56
Bayer Healthcare Pharmaceuticals Inc.2$52
Boehringer Ingelheim Pharmaceuticals, Inc.2$47

Products named: Ozempic, JARDIANCE, NURTEC ODT, FREESTYLE LIBRE 3, Veozah, BREZTRI, TRELEGY ELLIPTA, ELIQUIS.

Industry payments across MD — which companies pay providers there.